| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |